KLRS
Kalaris Therapeutics, Inc.
NASDAQ: KLRS · HEALTHCARE · BIOTECHNOLOGY
$5.52
+0.18% today
Updated 2026-04-30
Market cap
$138.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.85
Dividend yield
—
52W range
$2 – $12
Volume
0.1M
Kalaris Therapeutics, Inc. (KLRS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-308.10%
ROA
-45.10%
Debt/equity
0.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $1.14M | $-2.43M | — | -316.83% | -214.10% |
| 2019 | $165000.00 | $-23.84M | — | -16,182.42% | -14,447.88% |
| 2020 | — | $-69.78M | — | — | — |
| 2021 | — | $-171.96M | — | — | — |
| 2022 | $0.00 | $-15.48M | — | — | — |
| 2023 | $0.00 | $-14.70M | — | — | — |
| 2024 | $0.00 | $-58.77M | — | — | — |
| 2025 | $0.00 | $-43.44M | — | — | — |